Assistant Professor of Psychiatry and Behavioral Sciences, Emory University School of Medicine
Professional Experience
Assistant Professor of Psychiatry, Madras University Medical College, Chennai, India, 1988-1994
Assistant Professor of Psychiatry and Biobehavioural Sciences, University of California, Los Angeles, 2003-2006
Assistant Professor of Psychiatry and Behavioural Sciences, Atlanta, GA
Education & Training
Bachelor of Medicine & Surgery (MBBS), Madurai University Medical College, India, 1975-1981.
Doctorate in Medicine (Psychiatry), Madras University Medical College, India, 1982-1984
Residency in Psychiatry, Yale University 1994-1998
Awards
Seymour L Lustman Award, Yale University, 1997
Paul E Kaunitz Award, Yale University, 1998
Young Investigator Award, National Association for Research on Schizophrenia and Affective Disorders, 2010
Career Development Award, National Institute of Mental Health,
New Investigator Award, American Society for Clinical Psychopharmacology – NCDEU, 2013
Research Grants
R01MH107033, Inflammation-Induced CNS Glutamate as a Function of Depression in Middle Age. National Institute of Mental Health
R01MH112076, Inflammation-Induced CNS Changes as A Function Of Depression, National Institute of Mental Health
Committee & Membership
Scientific Program Committee, American Society for Clinical Psychopharmacology.
Scientific Program Committee, Society for Biological Psychiatry
Editorial Board, Brain, Behavior and Immunity.
Selected Publication
Haroon E, Watari K, Thomas A, Ajilore O, Mintz J, Elderkin-Thompson V, et al. (2009): Prefrontal myo-inositol concentration and visuospatial functioning among diabetic depressed patients. Psychiatry Res. 171:10-19.
Haroon E, Raison CL, Miller AH (2012): Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology. 37:137-162.
Haroon E, Woolwine BJ, Chen X, Pace TW, Parekh S, Spivey JR, et al. (2014): IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy. Neuropsychopharmacology. 39:1777-1785.
Haroon E, Felger JC, Woolwine BJ, Chen X, Parekh S, Spivey JR, et al. (2015): Age-related increases in basal ganglia glutamate are associated with TNF, reduced motivation and decreased psychomotor speed during IFN-alpha treatment: Preliminary findings. Brain Behav Immun. 46:17-22.
Haroon E, Fleischer CC, Felger JC, Chen X, Woolwine BJ, Patel T, et al. (2016): Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression. Mol Psychiatry. 21:1351-1357.
Haroon E, Mayberg H (2017): Brain Imaging in Psychopharmacology. In: Schatzberg AF, Nemeroff CB, editors. American Psychiatric Publishing Textbook of Psychopharmacology, Fifth Edition ed. Arlington, VA: The American Psychiatric Press pp 239-277.
Haroon E, Miller AH (2017): Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications. Curr Top Behav Neurosci. 31:173-198.
Haroon E, Miller AH (2017): Inflammation Effects on Glutamate as a Pathway to Neuroprogression in Mood Disorders. Mod Trends Pharmacopsychiatry. 31:37-55.
Haroon E, Miller AH, Sanacora G (2017): Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders. Neuropsychopharmacology. 42:193-215.
Haroon E, Daguanno AW, Woolwine BJ, Goldsmith DR, Baer WM, Wommack EC, et al. (2018): Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder. Psychoneuroendocrinology. 95:43-49
